Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pharming Group N.V. ADR (PHAR)

Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pharming Group N.V. ADR DARWINWEG 24 LEIDEN P7 2333 CR NLD

www.pharming.com Employees: 404 P: 31-71-524-7400 F: +31 715247445

Sector:

Medical

Description:

Pharming Group N.V. is a commercial stage biopharmaceutical company. It engages in developing protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs. The company's product portfolio includes C1INH. Pharming Group N.V. is based in Leiden, The Netherlands.

Key Statistics

Overview:

Market Capitalization, $K 1,219,567
Enterprise Value, $K 1,168,877
Shares Outstanding, K 68,515
Annual Sales, $ 297,200 K
Annual Net Income, $ -11,840 K
Last Quarter Sales, $ 97,300 K
Last Quarter Net Income, $ 7,500 K
EBIT, $ 26,240 K
EBITDA, $ 42,310 K
60-Month Beta 0.00
% of Insider Shareholders 2.07%
% of Institutional Shareholders 0.03%
Float, K 67,097
% Float 97.93%
Short Interest 14
Short Float 0.02%
Short Volume Ratio 0.74

Growth:

1-Year Return 67.92%
3-Year Return 61.38%
5-Year Return 17.14%
5-Year Revenue Growth 57.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.10 on 11/06/25
Next Earnings Date 03/12/26
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Qtr 66.67%
EPS Growth vs. Prev Year 600.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PHAR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 86.14
Price/Earnings to Growth N/A
Return-on-Equity % 0.46%
Return-on-Assets % 0.25%
Profit Margin % -3.98%
Debt/Equity 0.02
Price/Sales 4.17
Price/Cash Flow 244.04
Price/Book 4.68
Book Value/Share 3.86
Interest Coverage -0.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar